newsfilter
← Latest News
PR Newswire·

BrainStorm Cell Therapeutics to Provide Corporate Mid-Year Update on NurOwn Program

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced today ...